<DOC>
	<DOCNO>NCT02956369</DOCNO>
	<brief_summary>SATIOSTAT composition comprise specific dietary fibre component ( mixture hydrocolloid excellent safety profile long history use human ) lipid component ( long-chain fatty acid ) . The goal combination achieve long-acting delivery long-chain fatty acid intestinal lining , trigger sustained release satiety-signals intestinal cell , consequently reduce appetite lower food intake human . Over period 6 week , volunteer ingest SATIOSTAT meal replacement lunch first course dinner . Once 6 week investigator carry oral glucose challenge , measure satiation hormone examine faeces ( gut microbiota ) . Volunteers fill food diary questionnaire gastrointestinal symptom quality life . The whole study take approximately 8-10 week .</brief_summary>
	<brief_title>Effect Daily Intake SATIOSTAT Over 6 Weeks Weight Loss , Glucose Tolerance , Gastrointestinal Tolerance Gut Microbiota .</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Obese volunteer ( BMI &gt; 30kg/m2 ) Otherwise healthy Informed Consent document signature ( Appendix Informed Consent Form ) Food allergy , food intolerance Evidence relevant cardiovascular , pulmonary , renal , hepatic , pancreatic , gastrointestinal , metabolic , endocrinological , neurological , psychiatric disease screen Chronic clinically relevant acute infection Clinically relevant abnormality chemical , haematological laboratory parameter Participation drug trial within 2 month start study Neurological psychiatric disease drug alcohol abuse , would interfere subject proper completion protocol assignment Pregnancy : although contraindication pregnancy might influence metabolic state . Women pregnant intention become pregnant course study exclude . In female participant childbearing age use safe contraception ( oral , injectable , implantable contraceptive , intrauterine contraceptive device ) urine pregnancy test carry upon screen . Antibiotic therapy within last 3 month inclusion Substance abuse , alcohol abuse Inability follow procedure due psychological disorder , dementia insufficient Knowledge project language ( German ) . Participation another study investigational drug within 30 day precede present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>